Impact of Next-Generation Sequencing Analyses on Treatment Management of Patients with Advanced Neuroendocrine Neoplasms
Introduction: Molecular genomic analyses are widely used in oncology but experience in advanced neuroendocrine neoplasms (NENs) is still limited.
Aim(s): We have analyzed the sensibility to detect genomic aberrations in advanced NENs and the potential impact in the treatment decision process.
Materials and methods: We selected the last correlative 100 patients (pts) with advanced NENs in which next-generation sequencing (NGS) analyses were performed. Two different NGS techniques were used on formalin fixed paraffin embedded archival tumor samples: amplicon-seq for detection of DNA mutations and nanostring n-counter for fusions and copy number alterations.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Garcia Alvarez A
To read the full abstract, please log into your ENETS Member account.